期刊文献+

肝细胞癌凋亡抑制蛋白bcl-2和bcl-xl与VEGF、bFGF及血管生成的关系 被引量:3

Correlation of the Apoptosis Inhibitive Proteins (bcl-2 and bcl-xl) and VEGF,bFGF and Angiogenesis in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的 :探讨原发性肝细胞癌 (HCC)组织中凋亡抑制蛋白bcl 2和bcl xl的表达与血管内皮生长因子 (VEGF)、碱性成纤维细胞生长因子 (bFGF)以及血管生成之间的关系。方法 :对经病理证实的肝细胞癌 38例共 4 0个癌灶进行分析 ,用免疫组化SP法检测癌组织中VEGF、bFGF、bcl 2和bcl xl的表达以及微血管密度 (MVD) ,分析它们之间的相互关系。结果 :VEGF、bFGF、bcl 2和bcl xl的阳性表达率分别为 77 5 % (31/4 0 )、75 % (30 /4 0 )、2 7 5 % (11/4 0 )和 5 0 % (2 0 /4 0 ) ,所有病灶的平均MVD为 39 3± 8 4 0。VEGF与bFGF、bcl 2与bcl xl之间明显相关 (P <0 0 1)。VEGF与bcl 2之间也存在一定的相关性 (P <0 0 5 )。在VEGF、bcl xl的阴性和阳性表达组MVD均具有显著的差异 (P <0 0 5 )。结论 :VEGF、bFGF与bcl 2、bcl xl之间具有一定的关系 ,VEGF和bcl Objective:To explore the correlation of the apoptosis inhibitive proteins including bcl-2 and bcl-xl and the vascular endothelial growth factor (VEGF),basic fibroblast growth factor (bFGF) and angiogenesis in hepatocellular carcinoma (HCC).Methods:Thirty-eight cases (40 lesions) of HCC verified by histopathology were studied.The microvessel density (MVD) and the expressions of VEGF,bFGF,bcl-2 and bcl-xl were detected with immunohistochemical SP method,and the relationships among these results were analysed.Results:The positive rate of VEGF,bFGF,bcl-2 and bcl-xl was 77.5%(31/40),75%(30/40),27.5%(11/40) and 50%(20/40) in HCC respectively,and the mean MVD was 39.3±8.40.The correlations between VEGF and bFGF,and between bcl-2 and bcl-xl were found (P<0.01 respectively).The same result was also found between VEGF and bcl-2 (P<0.05).The MVD was higher in the positive expression group of bcl-xl or VEGF than in the negative expression ones (P<0.05 respectively).Conclusion:There are some correlation among the proteins as VEGF,bFGF,bcl-2 and bcl-xl,and the angiogenesis in HCC may be regulated by the expressions of VEGF and bcl-xl.
出处 《临床肿瘤学杂志》 CAS 2004年第6期565-567,共3页 Chinese Clinical Oncology
基金 山东省科技厅资助课题 (项目编号 1998BB1CCA1)
关键词 VEGF bcl-2 FGF BCL-XL bcl—xl 血管生成 凋亡抑制蛋白 肝细胞癌 MVD HCC Hepatocellular carcinoma Apoptosis inhibitive protein Neovascularization,pathological Vascular endothelial growth factor Basic fibroblast growth factor
  • 相关文献

参考文献8

  • 1Folkman J,Shing Y.Angiogenesis[J].J Biol Chem,1992,267(16):10931-10934.
  • 2Riedel F,Gotte K,Bergler W,et al.Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck[J].Oncol Rep,2001,8(3):471-476.
  • 3West A F,ODonnell M,Charlton R G,et al.Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer[J].Br.J Cancer,2001,85(4):576-583.
  • 4El-Assal ON,Yamanoi A,Soda Y,et al.Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver:possilbe involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver[J].Hepatology,1988,27(6):1554-1562.
  • 5Poon RT,Ng IO,Lau C,et al.Correlation of serum basic fibroblost growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma[J].Am J Surg,2001,182(3):298-304.
  • 6Nor JE,Christensen J,Liu J,et al.Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth[J].Cancer Res,2001,61(5):2183-2188.
  • 7Pidgeon GP,Barr MP,Harmey JH,et al.Vascular endothelial growth factor(VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells[J].Br J Cancer,2001,85(2):273-278.
  • 8Takehara T,Liu X,Fujimoto J,et al.Expression and role of Bcl-xl in human hepatocellular carcinomas[J].Hepatology,2001,34(1):55-61.

同被引文献28

  • 1解骅,熊旭林,鲁功成.BPH组织中bFGF、bFGFR表达及其对前列腺组成的影响[J].中华泌尿外科杂志,1996,17(4):238-240. 被引量:5
  • 2Weidner N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol, 1995, 147(1):9-19.
  • 3Aigner A, Butscheid M, Kunkel P, et al. An FGF-binding protein exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell preliferation through FGF-2 release[J]. Int J Cancer, 2001, 92(4):510-517.
  • 4West AF, O'Donnell M, Charhon RG, et al. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer[J]. B J Cancer, 2001, 85(4):576-583.
  • 5Pallares J, Rojo F, Ifiarte J, et al. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues[J]. Histol Histopathol, 2006, 21(8) :857- 865.
  • 6Strohmeyer D, Strauss F, Rossing C, et al. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma [J]. Antieancer Res, 2004, 24(3a) : 1797-1804.
  • 7Levine AC, Liu XH, Greenberg PD, et al. Androgens induced the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts[J]. Endocrinology, 1998, 139(11):4672-4678.
  • 8Walsh K, Sriprasad S, Hopster D, et al. Distribution of vascular endothelial growth factor (VEGF) in prostate disease [J]. Prostate Cancer Prostatic Dis, 2002, 5(2) : 119-122.
  • 9Deering RE, Bigler SA, Brown M, et al. Microvascularity in benign prostatic hyperplasia[J]. Prostate, 1995, 26(3) : 111-115.
  • 10Stefanou D, Batistatou A, Kamina S, et al. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer[J]. In Vivo, 2004, 18(2):155-160.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部